ArticleThe Journal of clinical endocrinology and metabolism2021

Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.

Aaron Broadwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.